WelcomeThe Ophthalmic Oncology Group (OOG) is an independent scientific group devoted to clinical ophthalmic oncology and related basic-science research.
The aims of the OOG are to:
Membership payment
The OOG annual membership fee is 30 EUR.
Please click here to download the payment details or email Dr Ulrich Pfeffer to pay your fees. Donations by third parties are welcome and may be paid in the same manner. |
NewsNext meeting:
60th meeting, London, UK, 2-4 July 2026 Join waiting list 
59th meeting, Genoa 2025Thank you for a wonderful meeting!
https://oog2025.it/ |
Published OOG studies
Stålhammar G, Vishnevskia-Dai V, Verdijk RM, Moulin A. Expert Opinions on Uveal Melanoma: Insights from the 58th Ophthalmic Oncology Group Meeting. Ocul Oncol Pathol. 2024. https://doi.org/10.1159/000541016
van Poppelen N, Cassoux N, Turunen JA, et al. The Pediatric and Young Adult Choroidal and Ciliary Body Melanoma Genetic Study, A Survey by the European Ophthalmic Oncology Group. Invest Ophthalmol Vis Sci. 2024;65:1-9. https://doi.org/10.1167/iovs.65.4.12
Cunha Rola A, Taktak A, Eleuteri A, et al. Multicenter External Validation of the Liverpool Uveal Melanoma Prognosticator Online: An OOG Collaborative Study. Cancers (Basel). 2020;12:477. doi:10.3390/cancers12020477
Jouhi S, Jager MJ, de Geus SJR, et al. The Small Fatal Choroidal Melanoma Study. A Survey by the European Ophthalmic Oncology Group. Am J Ophthalmol. 2019;202:100-108.
doi.org/10.1016/j.ajo.2019.01.031
Kivelä TT, Piperno-Neumann S, Desjardins L, et al. Validation of a prognostic staging for metastatic uveal melanoma: a collaborative study of the European Ophthalmic Oncology Group. Am J Ophthalmol. 2016;168:217–226.
doi.org/10.1016/j.ajo.2016.06.002
Al-Jamal RT, Cassoux N, Desjardins L, et al. The Pediatric Choroidal and Ciliary Body Melanoma Study: A Survey by the European Ophthalmic Oncology Group. Ophthalmology. Apr 2016;123(4):898-907.
doi.org/10.1016/j.ophtha.2015.12.024
Stålhammar G, Vishnevskia-Dai V, Verdijk RM, Moulin A. Expert Opinions on Uveal Melanoma: Insights from the 58th Ophthalmic Oncology Group Meeting. Ocul Oncol Pathol. 2024. https://doi.org/10.1159/000541016
van Poppelen N, Cassoux N, Turunen JA, et al. The Pediatric and Young Adult Choroidal and Ciliary Body Melanoma Genetic Study, A Survey by the European Ophthalmic Oncology Group. Invest Ophthalmol Vis Sci. 2024;65:1-9. https://doi.org/10.1167/iovs.65.4.12
Cunha Rola A, Taktak A, Eleuteri A, et al. Multicenter External Validation of the Liverpool Uveal Melanoma Prognosticator Online: An OOG Collaborative Study. Cancers (Basel). 2020;12:477. doi:10.3390/cancers12020477
Jouhi S, Jager MJ, de Geus SJR, et al. The Small Fatal Choroidal Melanoma Study. A Survey by the European Ophthalmic Oncology Group. Am J Ophthalmol. 2019;202:100-108.
doi.org/10.1016/j.ajo.2019.01.031
Kivelä TT, Piperno-Neumann S, Desjardins L, et al. Validation of a prognostic staging for metastatic uveal melanoma: a collaborative study of the European Ophthalmic Oncology Group. Am J Ophthalmol. 2016;168:217–226.
doi.org/10.1016/j.ajo.2016.06.002
Al-Jamal RT, Cassoux N, Desjardins L, et al. The Pediatric Choroidal and Ciliary Body Melanoma Study: A Survey by the European Ophthalmic Oncology Group. Ophthalmology. Apr 2016;123(4):898-907.
doi.org/10.1016/j.ophtha.2015.12.024
MEMBERSHIP AREAMembership is open to clinicians and basic scientists working in the field of ophthalmic oncology and a willingness to contribute to the OOG. |
INFORMATION AREAThis area offers information about tumours, tests and treatments, as well as access to the specialist centres across Europe. |
PRACTITIONER AREAThis private members area has been developed to provide practitioners with access to case studies, general information, and to facilitate open discussion. |
